Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: J Mol Med (Berl). 2014 Jun 8;92(9):995–1007. doi: 10.1007/s00109-014-1162-1

Fig 4. p38 and JNK but not the ERK pathway are involved in O2-induced DA contraction.

Fig 4

(A) and (B): Relationship of the effect of ansomycin (p38 and JNK activator) on DA tension change and subsequent O2-induced DA tension change (n=5). (C) Different inhibitor experiments indicate that the p38 and JNK pathways are necessary for O2-mediated DA contraction. SB203580 (p38 inhibitor); PD98059 (ERK inhibitor); LY294002 and Wortmannin (PI3-kinase inhibitor).